Tranexamic Acid During Radical Cystectomy Does Not Lead to Blood Transfusion Reduction in Bladder CancerThe use of prophylactic tranexamic acid ...
The FDA withdrew Trodelvy for locally advanced or metastatic urothelial carcinoma; however, this does not affect other indication of the ...
FDA Accepts New Drug Application for UGN-102 in Bladder CancerA new drug application (NDA) has been accepted by the Food ...
The study found that Opdivo and Abraxane were effective and safe in treating muscle-invasive bladder cancer.Opdivo (nivolumab) with Abraxane (nab-paclitaxel) ...
Patients with high-risk muscle-invasive urothelial carcinoma (MIUC) who underwent radical surgery experienced notable improvements in disease-free survival (DFS, the time ...
Trodelvy shows promise as a potential treatment option for patients with advanced or metastatic bladder cancer who have progressed after ...
Patients with muscle-invasive bladder cancer who are not eligible or refuse to receive presurgical gemcitabine chemotherapy demonstrated responses to TAR-200 ...
Patients with cisplatin-eligible muscle-invasive bladder cancer (MIBC) who received neoadjuvant (treatment as the first step to shrink a tumor) Imfinzi ...
When CRAMER received his diagnosis, his mom left her career to be his full-time caregiver.CRAMER, right, and his mom, ASHLEE, ...
Dose-dense gemcitabine and cisplatin may be beneficial to patients with locally advanced bladder cancer. The treatment of preoperative dose-dense gemcitabine ...
When considering health-related quality of life, it’s important to think about the “small changes” patients with kidney or bladder cancers ...
It's important for patients with kidney cancer and bladder cancer to be aware of their physical functioning because it plays ...
